Relapsed Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB00441 | Gemcitabine | A nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01262 | Decitabine | 0 | Completed | 1 |
DB09037 | Pembrolizumab | 0 | Completed | 1 |
DB09331 | Daratumumab | 1 | Terminated | 1 |
DB01234 | Dexamethasone | 1 | Terminated | 1 |
DB00480 | Lenalidomide | 1 | Terminated | 1 |
DB18746 | Ocifisertib | 1 | Completed | 1 |
DB19137 | Batoprotafib | 1 / 2 | Unknown Status | 1 |
DB11967 | Binimetinib | 1 / 2 | Unknown Status | 1 |
DB14707 | Cemiplimab | 1 / 2 | Recruiting | 1 |
DB08865 | Crizotinib | 1 / 2 | Unknown Status | 1 |
DB13874 | Enasidenib | 1 / 2 | Terminated | 1 |
DB09053 | Ibrutinib | 1 / 2 | Recruiting | 1 |
DB12130 | Lorlatinib | 1 / 2 | Unknown Status | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
DB11581 | Venetoclax | 1 / 2 | Terminated | 1 |
DB15719 | Belantamab mafodotin | 2 | Not Yet Recruiting | 1 |
DB06769 | Bendamustine | 2 | Recruiting | 1 |
DB01234 | Dexamethasone | 2 | Not Yet Recruiting | 1 |
DB16672 | Epcoritamab | 2 | Recruiting | 1 |
DB14811 | Isatuximab | 2 | Not Yet Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB00642 | Pemetrexed | 2 | Recruiting | 1 |
DB08910 | Pomalidomide | 2 | Not Yet Recruiting | 1 |
DB15035 | Zanubrutinib | 2 | Recruiting | 1 |
DB16655 | Teclistamab | 4 | Not Yet Recruiting | 1 |
DB06273 | Tocilizumab | 4 | Not Yet Recruiting | 1 |